SCHEMBL1608029

SCHEMBL1608029

CCC1(C)OC(C)=C(O)C1=O

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11624782 0.83 TYR (0.30) TYR
SCHEMBL8905163 0.80
SCHEMBL4202988 0.73 TYR (0.39) TYR
SCHEMBL8905806 0.72
SCHEMBL17143362 0.71 TYR (0.33) TYR
SCHEMBL11619517 0.71
SCHEMBL11622192 0.67 PTPN1 (0.31) TYR
SCHEMBL887992 0.66
SCHEMBL9404445 0.62 SIGMAR1 (0.33)
SCHEMBL13265136 0.61 PTGS2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 469 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12568998-B2 Flavouring composition with balanced taste profile SYMRISE AG (DE) 2026-03-10 US claimed
EP-4444108-B1 ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT SYMRISE AG (DE) 2025-09-10 EP claimed
EP-4565194-A1 ODOR AND COLORANT STABILIZED COMPOSITIONS Symrise AG (DE) 2025-06-11 EP claimed
US-20250163006-A1 New Coolants, and Preparations Containing Same SYMRISE AG (DE) 2025-05-22 US claimed
US-20250040580-A1 ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT SYMRISE AG (DE) 2025-02-06 US claimed
WO-2025026525-A1 HETEROCYCLIC COMPOUNDS AS PHYSIOLOGICAL COOLANTS SYMRISE AG (DE) 2025-02-06 WO claimed
EP-4469439-A1 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME Symrise AG (DE) 2024-12-04 EP claimed
EP-3689324-B1 NEW COOLING AGENTS AND PREPARATIONS COMPRISING THEM SYMRISE AG (DE) 2024-11-20 EP claimed
EP-4444108-A1 ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT Symrise AG (DE) 2024-10-16 EP claimed
US-20240245085-A1 FLAVORING COMPOSITIONS FOR TASTE IMPROVEMENT SYMRISE AG (DE) 2024-07-25 US claimed
US-9005688-B2 Thermally stable high impact flavoring particles SYMRISE AG (DE) 2015-04-14 US claimed
WO-2014159458-A1 DISPOSABLE BEVERAGE POD AND APPARATUS FOR MAKING A BEVERAGE Altria Client Services Inc. (US) 2014-10-02 WO claimed
WO-2014152558-A2 FLAVOR SYSTEM AND METHOD FOR MAKING BEVERAGES SCHUH CHRISTIAN (US) 2014-09-25 WO claimed
US-20140272019-A1 DISPOSABLE BEVERAGE POD AND APPARATUS FOR MAKING A BEVERAGE Altria Client Services Inc. (US) 2014-09-18 US claimed
US-20140272006-A1 FLAVOR SYSTEM AND METHOD FOR MAKING BEVERAGES Altria Client Services Inc. (US) 2014-09-18 US claimed
EP-2742983-A1 Method for isolating fragrance and flavour compounds Symrise AG (DE) 2014-06-18 EP claimed
EP-2559346-B1 Oleanene-type triterpene glycosides as masking agents SYMRISE AG (DE) 2014-03-26 EP claimed
WO-2013023891-A1 OLEANENE-TYPE TRITERPENE GLYCOSIDES AS MASKING AGENTS SYMRISE AG (DE) 2013-02-21 WO claimed
EP-2559346-A1 Oleanene-type triterpene glycosides as masking agents Symrise AG (DE) 2013-02-20 EP claimed
US-20120107477-A1 THERMALLY STABLE HIGH IMPACT FLAVORING PARTICLES SYMRISE AG (DE) 2012-05-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12568998-B2 Flavouring composition with balanced taste profile TAS2R20, TAS2R50, TAS2R40 TYR 2629/4885
US-20250163006-A1 New Coolants, and Preparations Containing Same TTR, TAS2R5, TAS2R50 TYR 1295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.